This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To determine which prophylactic interventions reduce the incidence, severity, or both of adverse gastrointestinal effects among adults receiving radiotherapy to treat primary pelvic cancers
Funding Information: This work was supported by Cancer Research UK Programme grant [C5255/A23755]. C...
In those receiving radiotherapy for pelvic cancers, up to 80% develop gastrointestinal symptoms, wit...
Background: This is an update of a Cochrane review first published in 2002, and previously updated i...
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To determ...
Background Radiotherapy is an effective and key treatment for cancer, but pelvic radiotherapy can da...
Pelvic cancers are among the most frequently diagnosed cancers worldwide. Treatment of patients requ...
In the UK, about 90000 cancer survivors will suffer from pelvic radiation disease (PRD) due to their...
none3siGastrointestinal toxicity after radiotherapy for pelvic cancer is a major complication-the mo...
Pelvic cancers are among the most frequently diagnosed neoplasms and radiotherapy represents one of ...
Purpose of review Pelvic radiation disease in the form of chronic radiation-induced consequences of ...
This is the protocol for a review and there is no abstract. The objectives are as follows: To assess...
Background and purpose: Pelvic radiotherapy (RT) often results in gastrointestinal toxicity and clin...
Radiotherapy plays an important role in the treatment of pelvic tumors. The advances in patients’ pr...
The aim of this study was to review the available literature and define clinical practice guidelines...
PURPOSE: The aim of this study was to review the available literature and define clinical practice g...
Funding Information: This work was supported by Cancer Research UK Programme grant [C5255/A23755]. C...
In those receiving radiotherapy for pelvic cancers, up to 80% develop gastrointestinal symptoms, wit...
Background: This is an update of a Cochrane review first published in 2002, and previously updated i...
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To determ...
Background Radiotherapy is an effective and key treatment for cancer, but pelvic radiotherapy can da...
Pelvic cancers are among the most frequently diagnosed cancers worldwide. Treatment of patients requ...
In the UK, about 90000 cancer survivors will suffer from pelvic radiation disease (PRD) due to their...
none3siGastrointestinal toxicity after radiotherapy for pelvic cancer is a major complication-the mo...
Pelvic cancers are among the most frequently diagnosed neoplasms and radiotherapy represents one of ...
Purpose of review Pelvic radiation disease in the form of chronic radiation-induced consequences of ...
This is the protocol for a review and there is no abstract. The objectives are as follows: To assess...
Background and purpose: Pelvic radiotherapy (RT) often results in gastrointestinal toxicity and clin...
Radiotherapy plays an important role in the treatment of pelvic tumors. The advances in patients’ pr...
The aim of this study was to review the available literature and define clinical practice guidelines...
PURPOSE: The aim of this study was to review the available literature and define clinical practice g...
Funding Information: This work was supported by Cancer Research UK Programme grant [C5255/A23755]. C...
In those receiving radiotherapy for pelvic cancers, up to 80% develop gastrointestinal symptoms, wit...
Background: This is an update of a Cochrane review first published in 2002, and previously updated i...